Stock is losing groaund steadily from 87 cents and is now at 71...

  1. 57 Posts.
    lightbulb Created with Sketch. 2
    Stock is losing groaund steadily from 87 cents and is now at 71 cents. There could be 3 reasons:

    1. Nervous investors are locking profits
    2. Smart big timers are shaking the tree by scaring other investors and accumulating.
    3. Results are leaked and there is gradual unloading of stock until end of the year.

    It happens a lot with US biotechs. Just last Thursday, Immunocellular Therapeutics lost 60% of its value with a failed phase 2 trial. Funny thing is a few weeks before, it rallied from $2.20 to $4.00 and then steadily declined back to $2.70 before crashing to $1.10.

    The trajectory of BNO looks similar. Of course, Immunocellular had a very aggressing phase 2 goals unlike BNC105.

    I just hope that the results are in fact still blinded and ALL investors will know the result at the same time.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.